Elicio Therapeutics, Inc.

8-K Entered a material agreement; Other events Jul 2, 2026 8-K Regulation FD disclosure Jun 24, 2026 8-K Other events Jun 17, 2026 8-K Other events Jun 15, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 29, 2026 8-K Entered a material agreement; Terminated a material agreement Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Regulation FD disclosure; Other events Sep 17, 2025 8-K Other events Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Other events Aug 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jun 4, 2025 8-K Shareholder vote results May 20, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Director or officer change Mar 24, 2025 8-K Unregistered sale of equity Mar 5, 2025 8-K Entered a material agreement; Other events Jan 30, 2025 8-K Regulation FD disclosure Jan 23, 2025 8-K Other events Jan 22, 2025 8-K Regulation FD disclosure; Other events Dec 12, 2024 8-K Other events Dec 3, 2024 8-K Shareholder vote results Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Other events Nov 7, 2024 8-K Other events Nov 7, 2024 8-K Director or officer change Oct 17, 2024 8-K Director or officer change Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Aug 12, 2024